Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA.

导出 LinkOut

翻译打印收藏纠错

作者： Xiajie,Shi ^[1] ; Gan,Huang ^[2] ; Yanfei,Wang ^[1] ; Zhenqi,Liu ^[2] ; Chao,Deng ^[1] ; Xia,Li ^[2] ; Peilin,Zheng ^[3] ; Zhiguang,Zhou ^[1]

作者单位： Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. ^[1] Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China. ^[2] Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA. ^[3] Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. peilinz@csu.edu.cn. ^[4] Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China. peilinz@csu.edu.cn. ^[5] Department of Metabolism & Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China. zhouzhiguang@csu.edu.cn. ^[6] Key Laboratory of Diabetes Immunology, Central South University, Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, Hunan, China. zhouzhiguang@csu.edu.cn. ^[7]

关键词 Beta cell function Islet autoantibodies Latent autoimmune diabetes in adults Tetraspanin 7 Type 1 diabetes